Cargando…

A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo

The specific eradication of pathogenic T cells for the treatment of allograft rejections and autoimmune disorders without impairment of overall immune function is a fundamental goal. Here, cell-sized poly(lactic-co-glycolic acid) microparticles (PLGA MPs) were prepared as a scaffold to co-display th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei, Fang, Kun, Li, Miao-Chen, Chang, Di, Shahzad, Khawar Ali, Xu, Tao, Zhang, Lei, Gu, Ning, Shen, Chuan-Lai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914277/ https://www.ncbi.nlm.nih.gov/pubmed/26910923 http://dx.doi.org/10.18632/oncotarget.7519

Ejemplares similares

An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8(+) T Cells
por: Wang, Wei, et al.
Publicado: (2017)

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
por: Schütz, Christian, et al.
Publicado: (2014)

Novel Biodegradable Polymeric Microparticles Facilitate Scarless Wound Healing by Promoting Re-epithelialization and Inhibiting Fibrosis
por: Nosenko, Maxim A., et al.
Publicado: (2018)

Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
por: Weil, Sandra, et al.
Publicado: (2017)

Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis
por: Figueroa-Romero, Claudia, et al.
Publicado: (2022)

Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release
por: Benyamine, Audrey, et al.
Publicado: (2018)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo
por: Terry, Treniece L., et al.
Publicado: (2021)

Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo
por: Oyer, Jeremiah L., et al.
Publicado: (2022)

Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
por: Hermanson, David L., et al.
Publicado: (2015)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells
por: Choreño-Parra, José Alberto, et al.
Publicado: (2020)

Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury
por: Huang, Miao, et al.
Publicado: (2022)

The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens
por: Lang, Mark L.
Publicado: (2018)

Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
por: Brusko, Maigan A., et al.
Publicado: (2020)

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
por: Kang, Lin, et al.
Publicado: (2013)

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
por: Granzin, Markus, et al.
Publicado: (2017)

A bibliometric and scientific knowledge-map study of the chimeric antigen receptor (CAR) natural killer (NK) cell-related research from 2010 to 2022
por: Zhang, Juan, et al.
Publicado: (2022)

Impact of the Variable Killer Ig-Like Receptor–Human Leukocyte Antigen Interactions on Natural Killer Cell Cytotoxicity Toward Foreign CD4 T Cells
por: Hens, Jef, et al.
Publicado: (2018)

Biodegradable, bile salt microparticles for localized fat dissolution
por: Safari, Hanieh, et al.
Publicado: (2020)

Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis
por: Yarkoni, Shai, et al.
Publicado: (2014)

Microparticles in Autoimmunity: Cause or Consequence of Disease?
por: Rother, Nils, et al.
Publicado: (2022)

In vitro models to study natural killer cell dynamics in the tumor microenvironment
por: Carannante, Valentina, et al.
Publicado: (2023)

Regulation of sepsis-induced IFNγ upon natural killer cell or natural killer T cell depletion in vivo
por: Christaki, E, et al.
Publicado: (2012)

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
por: East, James E., et al.
Publicado: (2012)

Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma
por: Bogen, Jan P., et al.
Publicado: (2019)

Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants
por: Li, Ying, et al.
Publicado: (2021)

A humanized mouse model for in vivo evaluation of invariant Natural Killer T cell responses
por: Saavedra-Avila, Noemi Alejandra, et al.
Publicado: (2022)

Microparticles as Immune Regulators in Infectious Disease – An Opinion
por: Ling, Zheng Lung, et al.
Publicado: (2011)

Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
por: Sivonen, Minna, et al.
Publicado: (2023)

Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus
por: Burbano, Catalina, et al.
Publicado: (2018)

B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
por: Zhang, Zheng, et al.
Publicado: (2023)

In vivo natural killer and natural killer T-cell depletion affects mortality in a murine pneumococcal pneumonia sepsis model
por: Christaki, E, et al.
Publicado: (2012)

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
por: Lieberman, Nicole A. P., et al.
Publicado: (2018)

Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming
por: Capuano, Cristina, et al.
Publicado: (2018)

Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro
por: Tonelli, R. R., et al.
Publicado: (2013)

Assembly of Microparticles to Patterned Trenches Using the Depletion Volume Effect
por: Mori, Yaoki, et al.
Publicado: (2019)

In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10
por: Zhang, Qing, et al.
Publicado: (2022)

Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection
por: Hölzemer, Angelique, et al.
Publicado: (2017)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
por: Oberschmidt, Olaf, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h2p6o1at3u6b1tfnb8321vavod